Skip to main content

Mangoceuticals, Inc.

MGRX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
SEC CIK
0001938046

No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +1 vs. previous quarter
18
13F valueReported value at the end of Q2 2026
$455.6K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding MGRX, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding MGRX at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Mangoceuticals, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 17, 2025 (view filing)Dec 152 daysJohnston Eugene MCFOSSale−3.33K$1.17−$3.90K−2.7%120.0K after
Dec 11, 2025 (view filing)Dec 92 daysJohnston Eugene MCFOSSale−5.00K$1.20−$6.00K−3.9%123.3K after
Dec 9, 2025 (view filing)Dec 54 daysJohnston Eugene MCFOSSale−10.0K$1.13−$11.3K−7.2%128.3K after
Nov 26, 2025 (view filing)Nov 197 daysLateHamilton Alex P.DirectorSSale−125.0K$1.22−$152.5K−97.4%3.33K after
Jun 27, 2024 (view filing)6:25 PM ETJun 25-262 daysHamilton Alex P.DirectorSSale−125.0K$0.3187−$39.8K−71.4%50.0K after2 lots
May 2, 2023 (view filing)8:50 PM ETApr 1022 daysLateCohen Jacob D. and 1 otherChief Executive OfficerPPurchase+275.0K$1.00+$275.0K+3.4%8.28M after

Top 10 13F holders, Q2 2026

The largest institutional positions in Mangoceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 18 holders
Institutions holding MGRX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Citadel Advisors LLC338,964$128.8K0.00%+338,964New
XTX Topco Ltd186,256$70.8K0.00%+173,114+1,317.3%Added
Geode Capital Management, LLC156,243$59.4K0.00%−38,239−19.7%Reduced
Ikarian Capital, LLC138,146$52.5K0.01%00.0%Unchanged
Vanguard Capital Management LLC123,041$46.8K0.00%00.0%Unchanged
Vanguard Fiduciary Trust Co57,163$21.7K0.00%00.0%Unchanged
Boothbay Fund Management, LLC38,441$14.6K0.00%00.0%Unchanged
Northern Trust Corp37,579$14.3K0.00%00.0%Unchanged
Ackerman Capital Advisors, LLC34,500$13.1K0.00%00.0%Unchanged
HRT Financial LP36,003$13.0K0.00%+36,003New